Evidence map›Paper›PMID 36455041›Full record

ArticlePLoS biology2022

ERK1/2 signalling dynamics promote neural differentiation by regulating chromatin accessibility and the polycomb repressive complex.

Claudia I Semprich, Lindsay Davidson, Adriana Amorim Torres, Harshil Patel, James Briscoe, Vicki Metzis, Kate G Storey

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Nutrients · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claudia I SemprichDivision of Cell & Developmental Biology, School of Life Sciences, University of Dundee, Scotland, United Kingdom.
Lindsay DavidsonDivision of Cell & Developmental Biology, School of Life Sciences, University of Dundee, Scotland, United Kingdom.
Adriana Amorim TorresDivision of Cell & Developmental Biology, School of Life Sciences, University of Dundee, Scotland, United Kingdom.
Harshil PatelThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0003-2707-7940
James BriscoeThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-1020-5240
Vicki MetzisThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-0399-1722
Kate G StoreyDivision of Cell & Developmental Biology, School of Life Sciences, University of Dundee, Scotland, United Kingdom.ORCID 0000-0003-3506-1287
University of Dundee · GBThe Francis Crick Institute · GB

Funding

Cancer Research UK FC001051Medical Research Council FC001051Wellcome Trust 102817/Z/13/ZWellcome Trust 218536/Z/19/ZWellcome Trust FC001051
6 · The paper itself

Abstract

Fibroblast growth factor (FGF) is a neural inducer in many vertebrate embryos, but how it regulates chromatin organization to coordinate the activation of neural genes is unclear. Moreover, for differentiation to progress, FGF signalling must decline. Why these signalling dynamics are required has not been determined. Here, we show that dephosphorylation of the FGF effector kinase ERK1/2 rapidly increases chromatin accessibility at neural genes in mouse embryos, and, using ATAC-seq in human embryonic stem cell derived spinal cord precursors, we demonstrate that this occurs genome-wide across neural genes. Importantly, ERK1/2 inhibition induces precocious neural gene transcription, and this involves dissociation of the polycomb repressive complex from key gene loci. This takes place independently of subsequent loss of the repressive histone mark H3K27me3 and transcriptional onset. Transient ERK1/2 inhibition is sufficient for the dissociation of the repressive complex, and this is not reversed on resumption of ERK1/2 signalling. Moreover, genomic footprinting of sites identified by ATAC-seq together with ChIP-seq for polycomb protein Ring1B revealed that ERK1/2 inhibition promotes the occupancy of neural transcription factors (TFs) at non-polycomb as well as polycomb associated sites. Together, these findings indicate that ERK1/2 signalling decline promotes global changes in chromatin accessibility and TF binding at neural genes by directing polycomb and other regulators and appears to serve as a gating mechanism that provides directionality to the process of differentiation.

Indexed as

ChromatinMAP Kinase Signaling SystemAnimalsCell DifferentiationHumansMicePolycomb-Group ProteinsSignal TransductionChromatinPolycomb-Group Proteins

Identifiers

PMID36455041
PMCPMC9746999
OpenAlexW4310520688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.